# Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery

Study · id `cardio:ct-nct06414330` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06414330](<https://clinicaltrials.gov/study/NCT06414330>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06414330

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

## Technical summary

Registry record NCT06414330. Randomized; no masking; primary purpose prevention. Start 2024-06-01 (actual); primary completion 2025-11-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 124 participants (enrolled count; ClinicalTrials.gov record NCT06414330, source copy `cardio:ctgov-nct06414330-2025-12-22`, retrieved 2026-10-26)
- Started: 2024-06-01 (actual) (ClinicalTrials.gov record NCT06414330, source copy `cardio:ctgov-nct06414330-2025-12-22`, retrieved 2026-10-26)
- Primary completion: 2025-11-12 (actual) (ClinicalTrials.gov record NCT06414330, source copy `cardio:ctgov-nct06414330-2025-12-22`, retrieved 2026-10-26)
- Completion: 2025-12-01 (actual) (ClinicalTrials.gov record NCT06414330, source copy `cardio:ctgov-nct06414330-2025-12-22`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT06414330, source copy `cardio:ctgov-nct06414330-2025-12-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06414330-2025-12-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery
- Acronym: HTK
- Condition: Cardiac Ischemia
- Intervention (Biological): Ringer acetate based Del Nido cardioplegia
- Intervention (Biological): HTK
- Lead sponsor: Assiut University
- Lead sponsor class: OTHER
- Collaborator: Ahmed Ismail Abdelsabour
- Collaborator class: UNKNOWN
- Collaborator: Ramy Mustafa Abdelgawad Mohamed
- Collaborator class: UNKNOWN
- Collaborator: Ibrahim Mohamed Imbaby
- Collaborator class: UNKNOWN
- Collaborator: Amr Ibrahim Abdelaal
- Collaborator class: UNKNOWN
- Collaborator: Mahmoud Mohamed Atef Sallam
- Collaborator class: UNKNOWN
- Collaborator: Mohamed, Ahmed Abdelhay Mohamed
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Assiut University (`cardio:org-assiut-university`)

## Provenance

Content hash: 7d2c6cc70464fc2f4e106cf74cc1344f60a0243bb81cfb147dcebbdf742ebf85
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
